The importance of transporter genes and their variants in drug management and patients’ health becomes manifest, as other genetic variants present in SLCO superfamily genes are associated with DM2 incidence (SLCO1A2). The gene discussed is SLCO1A2; the disease is myotonic dystrophy type 2.